Derek Lowe – Page 6

  • Opinion

    Column: In the pipeline

    2011-06-30T09:50:26Z

    The financial markets can be a rollercoaster ride, writes Derek Lowe, so should chemists working in industry worry about the company share price?

  • Opinion

    Column: In the pipeline

    2011-05-31T11:23:38Z

    To the unfamiliar, chemists might all look the same. But some common categories are easy to identify, explains Derek Lowe

  • Opinion

    Column: In the pipeline

    2011-04-28T09:15:24Z

    The map of scientific disciplines is growing ever more complex. Derek Lowe surveys the country

  • Opinion

    Column: In the pipeline

    2011-03-30T08:37:00Z

    'Natural products are back!' is a headline Derek Lowe has seen several times before

  • Opinion

    Column: In the pipeline

    2011-02-24T10:48:16Z

    Drug discovery is an inherently risky business. Derek Lowe tries to balance some of the risk equations

  • Opinion

    Column: In the pipeline

    2011-01-31T09:55:05Z

    Enzymes have been giving chemists inferiority complexes since day one, says Derek Lowe. But there's no denying their potential

  • Opinion

    Column: In the pipeline

    2011-01-05T09:59:00Z

    Some medicinal chemists can't get enough fluorines in their molecules. Derek Lowe explains the love-hate relationship

  • Opinion

    Column: In the pipeline

    2010-11-29T13:25:21Z

    Who's that asleep at the back? Don't be too quick to blame yourself when tedious talks and soporific seminars fail to inspire, says Derek Lowe

  • Opinion

    Column: In the pipeline

    2010-10-28T10:14:50Z

    Should companies focus on big markets and the blockbuster dream? The more modern approaches are not without risks, says Derek Lowe

  • Opinion

    Column: In the pipeline

    2010-09-28T10:50:44Z

    Derek Lowe investigates the comeback combinatorial chemistry has made in the field of drug discovery

  • Opinion

    Column: In the pipeline

    2010-08-27T11:40:00Z

    Derek Lowe considers the quandaries of living in the age of the kinase

  • Opinion

    Column: In the pipeline

    2010-07-30T08:43:03Z

    Derek Lowe reminisces about lost laboratory techniques and wonders which will be next to go

  • Opinion

    Column: In the pipeline

    2010-06-25T11:37:54Z

    Derek Lowe ponders the possibility of phosphatase inhibitors

  • Opinion

    Column: In the pipeline

    2010-05-27T09:53:22Z

    Derek Lowe looks into his crystal ball to see what the future of medicinal chemistry might be

  • Opinion

    Column: In the pipeline

    2010-04-28T09:29:41Z

    Derek Lowe wonders whether tagging molecules with fluorescent labels for assay is like tracking the members of a shoal of fish by tying each one to a whale

  • Opinion

    Column: In the pipeline

    2010-03-31T08:05:07Z

    Derek Lowe waxes lyrical about the joys of the electronic lab notebook

  • Opinion

    Column: In the pipeline

    2010-02-26T10:39:37Z

    Derek Lowe takes a tour of the 'instrument graveyard'

  • Opinion

    Column: In the pipeline

    2010-01-28T13:45:41Z

    Derek Lowe wonders whether peer-reviewed papers or patents are more reliable

  • Opinion

    Column: In the pipeline

    2010-01-06T11:06:11Z

    Derek Lowe takes a look back over his 20 years as a medicinal chemist

  • Opinion

    Column: In the pipeline

    2009-11-26T11:35:17Z

    Is the pharmaceutical industry churning out copycat versions of existing therapies? Derek Lowe dispels a few myths about 'me-too' drugs